Jennifer Riley
Fortune : 733 582 $ au 30/06/2026
Fortune : 733 582 $ au 30/06/2026
Jennifer Riley is the founder of Northbrook Consulting LLC, founded in 2014.
Ms. Riley is currently Chief Strategy Officer at Avalo Therapeutics, Inc., starting in 2025.
Formerly, Ms. Riley was Vice President-Program Leadership & Management at Biogen, Inc. Ms. Riley completed undergraduate studies at the University of California San Diego and graduate studies at Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 39 696 ( 0,08% ) | 733 582 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national